These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

405 related articles for article (PubMed ID: 10470130)

  • 41. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
    Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
    J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Minichromosome maintenance-7 and geminin are reliable prognostic markers in patients with oral squamous cell carcinoma: immunohistochemical study.
    Tamura T; Shomori K; Haruki T; Nosaka K; Hamamoto Y; Shiomi T; Ryoke K; Ito H
    J Oral Pathol Med; 2010 Apr; 39(4):328-34. PubMed ID: 20136698
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Prognostic significance of cyclooxygenase-2 and DNA topoisomerase IIalpha expression in oral carcinoma.
    Sakurai K; Urade M; Noguchi K; Hashitani S; Takaoka K; Segawa E; Kishimoto H
    Head Neck; 2007 Nov; 29(11):1002-9. PubMed ID: 17427971
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Up-regulation of cyclooxygenase-2 in squamous carcinogenesis of the esophagus.
    Shamma A; Yamamoto H; Doki Y; Okami J; Kondo M; Fujiwara Y; Yano M; Inoue M; Matsuura N; Shiozaki H; Monden M
    Clin Cancer Res; 2000 Apr; 6(4):1229-38. PubMed ID: 10778945
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Expression of human DNA Topoisomerase II-alpha in squamous cell carcinoma of the larynx and its correlation with clinicopathologic variables.
    Shvero J; Koren R; Shvili I; Yaniv E; Sadov R; Hadar T
    Am J Clin Pathol; 2008 Dec; 130(6):934-9. PubMed ID: 19019771
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Expression of vascular endothelial growth factor (VEGF) and its receptors (Flt-1 and Flk-1) in esophageal squamous cell carcinoma.
    Kato H; Yoshikawa M; Miyazaki T; Nakajima M; Fukai Y; Masuda N; Fukuchi M; Manda R; Tsukada K; Kuwano H
    Anticancer Res; 2002; 22(6C):3977-84. PubMed ID: 12553021
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Retinoid receptors in human esophageal squamous cell carcinoma: retinoid X receptor as a potent prognostic factor.
    Fujishima F; Suzuki T; Nakamura Y; Taniyama Y; Ono K; Sugawara A; Miyazaki S; Moriya T; Sato A; Satomi S; Sasano H
    Pathol Int; 2011 Jul; 61(7):401-8. PubMed ID: 21707843
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Toll-like receptor 9 is a novel biomarker for esophageal squamous cell dysplasia and squamous cell carcinoma progression.
    Takala H; Kauppila JH; Soini Y; Selander KS; Vuopala KS; Lehenkari PP; Saarnio J; Karttunen TJ
    J Innate Immun; 2011; 3(6):631-8. PubMed ID: 21876325
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of Sialyl-Tn antigens in normal squamous epithelium, dysplasia, and squamous cell carcinoma in the esophagus.
    Ikeda Y; Kuwano H; Baba K; Ikebe M; Matushima T; Adachi Y; Mori M; Sugimachi K
    Cancer Res; 1993 Apr; 53(7):1706-8. PubMed ID: 8453646
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Micrometastasis and tumor cell microinvolvement of lymph nodes from esophageal squamous cell carcinoma: frequency, associated tumor characteristics, and impact on prognosis.
    Natsugoe S; Mueller J; Stein HJ; Feith M; Höfler H; Siewert JR
    Cancer; 1998 Sep; 83(5):858-66. PubMed ID: 9731887
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Expression of human telomerase reverse transcriptase (hTERT) protein is significantly associated with the progression, recurrence and prognosis of oral squamous cell carcinoma in Taiwan.
    Chen HH; Yu CH; Wang JT; Liu BY; Wang YP; Sun A; Tsai TC; Chiang CP
    Oral Oncol; 2007 Feb; 43(2):122-9. PubMed ID: 16798059
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Increased expression of ornithine decarboxylase messenger RNA in human esophageal carcinoma.
    Mafune K; Tanaka Y; Mimori K; Mori M; Takubo K; Makuuchi M
    Clin Cancer Res; 1999 Dec; 5(12):4073-8. PubMed ID: 10632342
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Study of indoleamine 2,3-dioxygenase expression in patients of esophageal squamous cell carcinoma].
    Sakurai K; Enomoto K; Amano S; Kimura T; Sugito K; Kimizuka K; Ikeda T; Shibata M; Negishi N
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1780-2. PubMed ID: 15553713
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Tumor suppressor Prdx1 is a prognostic factor in esophageal squamous cell carcinoma patients.
    Hoshino I; Matsubara H; Akutsu Y; Nishimori T; Yoneyama Y; Murakami K; Sakata H; Matsushita K; Ochiai T
    Oncol Rep; 2007 Oct; 18(4):867-71. PubMed ID: 17786348
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Expression of p53-related protein p63 in the gastrointestinal tract and in esophageal metaplastic and neoplastic disorders.
    Glickman JN; Yang A; Shahsafaei A; McKeon F; Odze RD
    Hum Pathol; 2001 Nov; 32(11):1157-65. PubMed ID: 11727253
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prognostic factors for the survival of patients with esophageal carcinoma in the U.S.: the importance of tumor length and lymph node status.
    Eloubeidi MA; Desmond R; Arguedas MR; Reed CE; Wilcox CM
    Cancer; 2002 Oct; 95(7):1434-43. PubMed ID: 12237911
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Survivin expression predicts poorer prognosis in patients with areca quid chewing-related oral squamous cell carcinoma in Taiwan.
    Lin CY; Hung HC; Kuo RC; Chiang CP; Kuo MY
    Oral Oncol; 2005 Jul; 41(6):645-54. PubMed ID: 15927524
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Coexpression of vascular endothelial growth factor and p53 protein in squamous cell carcinoma of the esophagus.
    Koide N; Nishio A; Hiraguri M; Hanazaki K; Adachi W; Amano J
    Am J Gastroenterol; 2001 Jun; 96(6):1733-40. PubMed ID: 11419822
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic implication of proliferative markers MIB-1 and PC10 in esophageal squamous cell carcinoma.
    Lam KY; Law SY; So MK; Fok M; Ma LT; Wong J
    Cancer; 1996 Jan; 77(1):7-13. PubMed ID: 8630942
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Expression of CXCL12 and its receptor CXCR4 in esophageal squamous cell carcinoma.
    Sasaki K; Natsugoe S; Ishigami S; Matsumoto M; Okumura H; Setoyama T; Uchikado Y; Kita Y; Tamotsu K; Hanazono K; Owaki T; Aikou T
    Oncol Rep; 2009 Jan; 21(1):65-71. PubMed ID: 19082444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.